Competitive problems in the drug industry: hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninety-first Congress, first session ...
United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities, United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
U.S. Government Printing Office, 1979 - Drugs
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
acetaminophen active addition Administration alcohol American analgesic appeared aspirin associated believe blood cause clinical codeine combination Committee compared compound concerning controlled Darvon DAWN deaths demonstrate dependence determine doctor doses drug abuse efficacy evaluation evidence experience fact factors fatalities Forensic Forensic Toxicology given Health hearings Hospital hydrochloride important increase indicates individual interest involved Journal less letter Lilly major medical examiner Medicine mentions million napsylate narcotic occur overdose pain patients percent persons physicians placebo effect placed potential practice prescribed prescription present problem propoxyphene psychological psychotherapy question reactions recent recommended record referred relative relief reported Research response Schedule Schedule II Sciences Senator NELSON showed side significant specific statement studies subjects Substances suggestibility suicide testimony therapeutic therapy tion toxicity Toxicology treatment United University